Disclaimer: This site analyses public FDA records. It is not medical advice. If you feel unwell, contact a healthcare professional immediately.
Supplement Safety Checker
Notice: Official Public Record

Martin Avenue Pharmacy, Inc. FDA Warning (2017)

Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on October 16, 2017

MODERATE SEVERITY 2017
Disclaimer: This report is an analysis of a public FDA warning letter. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately.

Executive Summary

The FDA issued a warning letter to Martin Avenue Pharmacy, Inc. on October 16, 2017 citing regulatory violations. The letter was issued by the FDA.

Regulatory Violations

Detailed Analysis

False Claims and Regulatory Violations

The FDA identified regulatory violations in Martin Avenue Pharmacy, Inc.'s operations or product claims.

Potential Health Risks

Division of Pharmaceutical Quality Operations III300 River Place, Suite 5900Detroit, MI 48207Telephone:(313) 393-8100Fax:(313) 393-8139

Roopinder Ahluwalia, PharmDPharmacist-in-ChargeMartin Avenue Pharmacy, Inc.1247 Rickert Drive, Suite 100Naperville, IL 60540

Nicholas F. LyonsDirector of ComplianceDivision of Pharmaceutical Quality Operations III

Regulatory Context

The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter (ref: WL# CHI-3-15) dated March 18, 2015. We acknowledge that your firm no longer produces sterile drug products. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.

You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Key Entities Identified

Martin Avenue Pharmacy Inc. FDA Warning Letter

Frequently Asked Questions

What did the FDA find wrong with Martin Avenue Pharmacy, Inc.?
The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
Are Martin Avenue Pharmacy, Inc. products safe to use?
Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
What should I do if I've used Martin Avenue Pharmacy, Inc. products?
If you have used products from Martin Avenue Pharmacy, Inc. and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.

Source Document

This report is based on an official FDA warning letter. The original document is a public record.

View Original FDA Warning Letter
Medical Disclaimer: This report is an analysis of public FDA warning letters. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately. You can report adverse events to the FDA MedWatch program.